Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers - Wikidata - wikimedia - TriplyDB

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

http://www.wikidata.org/entity/Q34274718

about

A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells.Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3 Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer System theoretical investigation of human epidermal growth factor receptor-mediated signalling.Down-regulation of vascular endothelial growth factor expression by anti-Her2/neu single chain antibodies.Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells.Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics.A COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms.Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion.The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response Neuregulin-1β regulation of embryonic endothelial progenitor cell survival.Integrated analysis reveals that STAT3 is central to the crosstalk between HER/ErbB receptor signaling pathways in human mammary epithelial cells.ErbB receptors in fetal endothelium--a potential linkage point for inflammation-associated neonatal disorders Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?Treatment of HER2-positive metastatic breast cancer following initial progression.Integrated experimental and model-based analysis reveals the spatial aspects of EGFR activation dynamics.Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.gamma-Secretase: a multifaceted regulator of angiogenesis The ERBB3 receptor in cancer and cancer gene therapy APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.Current insights on the biology and clinical aspects of VEGF regulation.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine.ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.Colorectal cancer in review: the role of the EGFR pathway.Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy.Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic options.Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.Endothelial ErbB4 deficit induces alterations in exploratory behavior and brain energy metabolism in mice.Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process.Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs.SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer.Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth.FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion.

P2860

Q26824462-86F4656F-57BF-435A-83A4-0EDF53D01CDF Q30486408-1A248377-AD08-41D2-ADFA-DF9840661DCD Q31129446-5CC1B389-B58C-438F-ADD0-459A3C232B12 Q33257718-76C21BE0-D942-42C0-8D4C-FD9F5541DA65 Q33388432-FCDB80B8-BB69-4695-8AA7-AF686CA44689 Q33803966-6C79C2FA-4C8E-456F-A3AC-7066C5CEDFA2 Q33840207-4D555386-AEDF-4076-9116-055C67FCFB1B Q33943812-018B09F2-4802-4BC9-81CD-06C1BE77E3AC Q34045675-15C91EE4-81AF-42F7-9091-0F9AEE8908D2 Q34095952-EA9387A4-4404-4763-ACF7-828BA3B19186 Q34197523-0945ED1C-C1E5-4D8B-8166-28ADD818A0B3 Q34243424-467B8FEC-B590-47E2-B3D0-FF1498E9E862 Q34345557-23F20947-308A-4D8B-8FDA-128DD723D4F3 Q34600838-3EB0E991-7612-4B5E-A0C8-716125878A61 Q34784406-A1CE7CC9-F6AF-443D-AE79-DBBA18EF6F0E Q35966355-80F24F0B-6B4B-4BC6-BA7C-F40059085473 Q36029983-4470FEA7-E7E8-43D6-BCE1-4BB5A0EEE4ED Q36116250-AD8361A5-6BA2-4057-B004-D8C055E06802 Q36187025-2E725327-E122-4C8E-A6D3-F1E404A66184 Q36275971-0D02633D-05C5-4A45-807A-164F1F9699F6 Q36367309-AAF0BCEE-300A-4B1B-9F52-E3D5BC8FF20D Q36943119-DD3EABB7-4BFC-4FF2-B058-5C968DE9068B Q37081791-A01826EF-1CA5-4E22-8FC4-709135B01490 Q37135372-C9CC9FDF-BE60-4DA0-86B6-50FD6C483870 Q37225352-5E65BCAC-087E-45E1-91B3-CC328CBC60B0 Q37272329-118D97DE-3839-4333-8967-7F1828096EF3 Q37351498-DFC10F70-FC33-4CD2-9095-96D5C830B5D9 Q37352618-92ECF3C5-0170-4FC4-ABFB-27E54EEB7E3A Q37668848-A0373364-47A5-4AF4-9262-E4E8B23C3885 Q37679938-BD307AF4-9CF6-4CCC-8742-09708B672BAE Q37827854-AF6578A5-2835-47B5-8E03-7A1DD06DFE9A Q38017118-CB00E8F4-1831-4A7B-8B84-EA361647B549 Q38440214-C5F746B1-C43E-4F1D-866A-8BAF0B15901B Q38831024-CEA4668B-F58F-4D64-A0CB-2BEB01202208 Q38899532-8DAB06E4-BBF8-41EA-8543-04664DC8092D Q38977467-755E0C3D-94CF-4AAC-AE9B-E27B788A1BDC Q39314472-0106B7BE-F842-4AFB-A580-46F545D6DD55 Q39484193-1AE3AB0D-D2E6-49DE-A099-C762DF053EC8 Q40177755-694BF3BF-89F8-4768-BE01-1D47577D09D7 Q40353474-90F0B21C-FD8A-41EB-B33D-518520D8FE80

P2860

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

http://www.wikidata.org/entity/Q34274718

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@ast

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@en

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@nl

type

label

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@ast

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@en

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@nl

prefLabel

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@ast

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@en

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@nl

P1433

Q34274718-830570B0-6F06-41E8-A45C-BEC81E57AFA3

P1476

Q34274718-C43F8BFE-9269-4747-80DB-2313989EBD01

P2093

Q34274718-0D164253-AB0B-44F2-AC9B-AF1AC2E863D2

Q34274718-1106E137-CEA8-4753-85EF-F26A0CCF6694

Q34274718-24E5EC4A-12B7-483B-B0FD-62E531440B21

Q34274718-47ADE0DC-C3EA-48AB-8613-51BECC36D971

Q34274718-7F2BE7F5-A55E-485E-A618-FCAB9CD67118

Q34274718-A7FCFADE-9E52-45BF-B6DC-29C888D0AA2C

Q34274718-B3AF00EA-C516-45DE-A62E-13212AC6FBC9

Q34274718-C46AF8B9-702E-40AA-8BA3-69A7FDC26D16

Q34274718-F022ADA9-896B-4B92-8B34-A1844D49CE8B

Q34274718-F57C76F2-C121-4739-AD5A-EE879C6DC58C

P2860

Q34274718-00F14105-1EE0-4D17-9674-866AB590B4A6

Q34274718-01607F59-7218-429A-87A0-687F4468EC8A

Q34274718-11CBF7FB-85A5-431B-BF6E-2C46E9929A4F

Q34274718-160DBA40-21C2-4193-909B-EB0CACBBD55E

Q34274718-1D71661D-BA2F-4661-8143-BE2E9C7A2BB6

Q34274718-22FBBDDC-09C5-41D2-B554-B868BEA0E5B6

Q34274718-26464971-263D-4D37-96CC-E8282CEB920F

Q34274718-26FC7ECD-1D0D-4523-891B-9A8F20E892A9

Q34274718-29655B2B-B02B-4389-9A0B-EAEF0E03A354

Q34274718-2DA5B6C8-A68B-4B36-945A-BBB50BF61444

P304

Q34274718-7438F5FE-3018-4039-9D53-EFC36E9B3710

P31

Q34274718-9D88E510-FCE5-48AF-AEC8-66209C980307

P356

Q34274718-B538C91C-92CB-4211-B119-44FBAED52A2D

P433

Q34274718-B093B9AB-8C64-4321-B484-0B0C97CBA1AC

P478

Q34274718-995FA725-907F-4533-B2A1-E688F9DD6509

P50

Q34274718-E996E5BE-B27A-4013-A007-3A13C2CD6B29

P577

Q34274718-865E44E6-E085-4BF4-B748-705A5E7C4F79

P698

Q34274718-EC4ABF4C-A3EF-4D50-839F-6CB55ABCD04F

P932

Q34274718-286C1DC0-C338-449E-B001-626B837E172A

P356

MBC.E02-02-0084

P1433

Molecular Biology of the Cell

P1476

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

@en

P2093

Ala-Eddin Al Moustafa

http://www.w3.org/2001/XMLSchema#string

Dingzhang Xiao

http://www.w3.org/2001/XMLSchema#string

Gilles Pages

http://www.w3.org/2001/XMLSchema#string

Hiroyasu Esumi

http://www.w3.org/2001/XMLSchema#string

Lily Yen

http://www.w3.org/2001/XMLSchema#string

Moulay A Alaoui-Jamali

http://www.w3.org/2001/XMLSchema#string

Naciba Benlimame

http://www.w3.org/2001/XMLSchema#string

Nancy E Hynes

http://www.w3.org/2001/XMLSchema#string

Taiqi Wang

http://www.w3.org/2001/XMLSchema#string

Zeng-Rong Nie

http://www.w3.org/2001/XMLSchema#string

P2860

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin

Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

Untangling the ErbB signalling network

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2

Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas

Epidermal growth factor-related peptides and their receptors in human malignancies

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

P304

4029-4044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1091/MBC.E02-02-0084

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12429844

http://www.w3.org/2001/XMLSchema#string

P932

133612

http://www.w3.org/2001/XMLSchema#string